Free Trial

Atria Wealth Solutions Inc. Has $1.54 Million Stock Position in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background

Key Points

  • Atria Wealth Solutions Inc. reduced its stake in Synopsys, Inc. by 47%, now holding 3,010 shares worth approximately $1.54 million, following the sale of 2,669 shares in the second quarter.
  • Several institutional investors, including Nuveen LLC and Pictet Asset Management, have increased their stakes in Synopsys, resulting in 85.47% of the stock being owned by institutional investors and hedge funds.
  • Wall Street analysts have adjusted their price targets for Synopsys, with recommendations ranging from "underperform" to "overweight," leading to a consensus rating of "Hold" and an average price target of $569.67.
  • Five stocks we like better than Synopsys.

Atria Wealth Solutions Inc. trimmed its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 47.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,010 shares of the semiconductor company's stock after selling 2,669 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in Synopsys were worth $1,544,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SNPS. Nuveen LLC acquired a new stake in Synopsys in the first quarter worth about $341,480,000. Pictet Asset Management Holding SA increased its position in Synopsys by 38.3% in the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock worth $1,043,518,000 after purchasing an additional 673,837 shares during the period. Generation Investment Management LLP acquired a new stake in Synopsys in the first quarter worth about $240,491,000. Vanguard Group Inc. boosted its holdings in Synopsys by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company's stock worth $6,359,747,000 after buying an additional 346,994 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in Synopsys by 22.2% during the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company's stock worth $739,857,000 after buying an additional 313,218 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on SNPS. Rosenblatt Securities restated a "neutral" rating and set a $605.00 target price (down previously from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. Bank of America restated an "underperform" rating and set a $525.00 target price (down previously from $625.00) on shares of Synopsys in a report on Wednesday, September 10th. KeyCorp reduced their target price on Synopsys from $660.00 to $590.00 and set an "overweight" rating on the stock in a report on Wednesday, September 10th. The Goldman Sachs Group reduced their target price on Synopsys from $700.00 to $600.00 and set a "buy" rating on the stock in a report on Wednesday, September 10th. Finally, Morgan Stanley cut their price objective on Synopsys from $715.00 to $510.00 and set an "overweight" rating on the stock in a report on Thursday, September 11th. Ten research analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $569.67.

View Our Latest Research Report on Synopsys

Insider Transactions at Synopsys

In related news, CFO Shelagh Glaser sold 3,655 shares of Synopsys stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $609.77, for a total value of $2,228,709.35. Following the sale, the chief financial officer owned 15,317 shares of the company's stock, valued at approximately $9,339,847.09. This trade represents a 19.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the business's stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the transaction, the chief accounting officer directly owned 20,520 shares in the company, valued at $10,278,468. This trade represents a 32.48% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 30,894 shares of company stock worth $16,760,783 in the last 90 days. 0.62% of the stock is owned by corporate insiders.

Synopsys Stock Up 1.0%

Shares of Synopsys stock opened at $440.20 on Friday. The business's 50 day simple moving average is $529.15 and its 200 day simple moving average is $510.15. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The firm has a market cap of $81.77 billion, a PE ratio of 34.55, a P/E/G ratio of 4.80 and a beta of 1.10. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period in the prior year, the business posted $3.43 EPS. The firm's quarterly revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.